SUDARSHAN PHARMA INDUSTRIES
Back to All Ratios
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 0.76 | 0.53 | 0.33 | 0.63 | 0.36 |
What is the latest Cash Earnings per Share (CEPS) ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 0.76 |
| Mar2024 | 0.53 |
| Mar2023 | 0.33 |
| Mar2022 | 0.63 |
| Mar2021 | 0.36 |
How is Cash Earnings per Share (CEPS) of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 0.76 | 43.40 | |
| Mar2024 | 0.53 | 60.61 | |
| Mar2023 | 0.33 | -47.62 | |
| Mar2022 | 0.63 | 75.00 | |
| Mar2021 | 0.36 | - | |
Other Financial Ratios of SUDARSHAN PHARMA INDUSTRIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,015.7 Cr | 4.6% | -1.3% | 17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 4.6% |
-1.3% |
17.3% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses